Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis

被引:51
作者
Rodríguez, MR [1 ]
Núñez-Roldán, A [1 ]
Aguilar, F [1 ]
Valenzuela, A [1 ]
García, A [1 ]
González-Escribano, MF [1 ]
机构
[1] Univ Sevilla, Hosp Vergen Rocio, Serv Inmunol, Serv Andaluz Salud, Seville 41013, Spain
关键词
CTLA4; rheumatoid arthritis; genetic susceptibility; genetic polymorphism;
D O I
10.1016/S0198-8859(01)00358-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T-lymphocyte antigen 4 (CTLA4) gene polymorphism located in the 3' untranslated region (UTR) was investigated in 141 Spanish patients (38 men and 103 women) with rheumatoid arthritis (RA) and in 194 ethnically-matched healthy controls. Twenty alleles having different numbers of (AT) repeats (from 7 to 32) were found in this population. (AT)(7) and (AT)(16) were the most frequent alleles, and accounted for almost two-thirds of the allelic frequency in the control population. Consequently, alleles were assigned as L (large: 16 or more AT repeats) or S (short: less than 16 AT repeats). When the US distribution in patients and controls were compared, an increase of L alleles was observed among patients (49.9%, vs. 39.7%; p = 0.02; p(c) = 0.04, odds ratio [OR] = 1.46; 95% confidence interval [CI], 1.06-2.01). Hence, the frequency of S alleles was decreased among patients (51.1% vs. 60.3%;p = 0.02;p(c) = 0.04; OR = 0.69; 95%CI, 0.50-0.95). Moreover, a statistically significant decrease in the frequency of S/S individuals was observed among RA patients (27.7% versus 40.7%; p = 0.01; p, = 0.03; OR = 0.56; 95%CI, 0.34-0.91). These differences were irrespective of the HLA "shared epitope" (SE) status, arid were observed similarly among SE+ as well as among SE- patients. After combining these data with other reported previously by us, from studies of CTLA4 49 (A/G) and -318 (C/T) polymorphisms, we conclude that the strongest association between CTLA4 gene polymorphisms and RA susceptibility occurs with the 3' UTR polymorphism. (C) American Society for Histocompatibility and Immunogenetics, 2002. Published by Elsevier Science Inc.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 36 条
[11]  
Harbo HF, 1999, TISSUE ANTIGENS, V53, P106
[12]  
HARPER K, 1991, J IMMUNOL, V147, P1037
[13]   Genetic association of Ctla-4 to myasthenia gravis with thymoma [J].
Huang, D ;
Li, L ;
Norén, K ;
Xia, SQ ;
Trifunovic, J ;
Pirskanen, R ;
Lefvert, AK .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) :192-198
[14]   Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis [J].
Huang, DR ;
Giscombe, R ;
Zhou, YH ;
Pirskanen, R ;
Lefvert, AK .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 105 (01) :69-77
[15]   CYTOPLASMIC REGULATION OF MESSENGER-RNA FUNCTION - THE IMPORTANCE OF THE 3' UNTRANSLATED REGION [J].
JACKSON, RJ .
CELL, 1993, 74 (01) :9-14
[16]  
Kawasaki ES, 1990, PCR PROTOCOLS GUIDE
[17]   CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease [J].
Kouki, T ;
Sawai, P ;
Gardine, CA ;
Fisfalen, ME ;
Alegre, ML ;
DeGroot, LJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6606-6611
[18]   Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children [J].
Lee, YJ ;
Huang, FY ;
Lo, FS ;
Wang, WC ;
Hsu, CH ;
Kao, HA ;
Yang, TY ;
Chang, JG .
CLINICAL ENDOCRINOLOGY, 2000, 52 (02) :153-157
[19]   Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups [J].
Marron, MP ;
Raffel, LJ ;
Garchon, HJ ;
Jacob, CO ;
SerranoRios, M ;
Larrad, MTM ;
Teng, WP ;
Park, Y ;
Zhang, ZX ;
Goldstein, DR ;
Tao, YW ;
Beaurain, G ;
Bach, JF ;
Huang, HS ;
Luo, DF ;
Zeidler, A ;
Rotter, JI ;
Yang, MCK ;
Modilevsky, T ;
Maclaren, NK ;
She, JX .
HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1275-1282
[20]   Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method [J].
Matsushita, M ;
Tsuchiya, N ;
Shiota, M ;
Komata, T ;
Matsuta, K ;
Zama, K ;
Oka, T ;
Juji, T ;
Yamane, A ;
Tokunaga, K .
TISSUE ANTIGENS, 1999, 54 (06) :578-584